EUVIMEDEUVIMED entdecken
Crossref

Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines

Medeiros, Sophia

PEARL (University of Plymouth) · 08.08.2024

DOI: 10.24382/6qvr-w034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PEARL (University of Plymouth), erschienen am 08.08.2024. Verfasst von Medeiros und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oral antidiabetic, metformin, has been documented to have antineoplastic activity in various cancer cell lines, associated with the inhibition of mitochondrial complex I. However, pre-clinical studies have struggled to demonstrate such antineoplastic activity utilising metformin concentrations attainable with standard antidiabetic dosing. Research has revealed that metformin combined with the anti-hypertensive drug, syrosingopine, lowers metformin’s therapeutic threshold and sensitizes cancer cells to killing, by inhibiting monocarboxylate transporters (MCT)1/MCT4. The potent interaction between these drugs elicits a synthetic lethality, specific to transformed cells. This preliminary study aimed to investigate metformin’s antineoplastic effects and its synergistic relationship with syrosingopine by measuring cell viability and extracellular lactate in PC3 (adherent) and THP-1 (suspension) cancer cell lines. Overall, the PC3 cell line responded better to treatment with combined doses of metformin and syrosingopine, or either drug alone; however, synthetic lethality was not observed in either cell line. In both cell lines, the interaction between metformin and syrosingopine was not statistically significant in the cell viability assays (p>0.05). Analysis of MCT1/MCT4 inhibition through the measurement of extracellular lactate was not statistically significant (p>0.05) and proved inconclusive. Additionally, the nature of the cell line, adherent or suspension, was statistically significant (p

Schlagwörter

metforminsyrosingopinesynthetic lethalityPC-3 cellsTHP-1 cellsprostate canceracute myeloid leukemiacancer cell lines

Zitieren

APA

Medeiros, & Sophia (2024). Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines. PEARL (University of Plymouth). https://doi.org/10.24382/6qvr-w034

Vancouver

Medeiros, Sophia. Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines. PEARL (University of Plymouth). 2024. doi:10.24382/6qvr-w034

BibTeX
@article{Medeiros2024,
  author = {Medeiros and Sophia},
  title = {Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines},
  journal = {PEARL (University of Plymouth)},
  year = {2024},
  doi = {10.24382/6qvr-w034}
}
Kostenlos starten →